Article Text

Download PDFPDF
Case control
The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus β blockers

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding CJP has received research grants Abbott Laboratories, the National Institutes of Health, Baxter, Pfizer, GlaxoSmithKline and Bioheart; is a consultant to Abbott Laboratories, Forest Labs, Novartis/Cleveland Clinic, NicOx, Angioblast, Sanofi-Aventis, Medtelligence and SLACK; and has received unrestricted educational grants from AstraZeneca, AtCor Medical, Daiichi Sankyo, Eli Lilly, Pfizer, Sanofi-Aventis and Schering-Plough.

  • Competing interests RCD has been received grant funding from Abbott Laboratories and the National Institutes of Health.